Elevation Oncology Statistics
Total Valuation
ELEV has a market cap or net worth of $15.38 million. The enterprise value is -$46.65 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ELEV has 59.22 million shares outstanding. The number of shares has increased by 56.82% in one year.
| Current Share Class | 59.22M |
| Shares Outstanding | 59.22M |
| Shares Change (YoY) | +56.82% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 47.05% |
| Float | 37.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.21, with a Debt / Equity ratio of 0.52.
| Current Ratio | 21.21 |
| Quick Ratio | 20.86 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.18 |
Financial Efficiency
Return on equity (ROE) is -77.48% and return on invested capital (ROIC) is -31.73%.
| Return on Equity (ROE) | -77.48% |
| Return on Assets (ROA) | -30.25% |
| Return on Invested Capital (ROIC) | -31.73% |
| Return on Capital Employed (ROCE) | -49.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 34 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELEV has paid $43,000 in taxes.
| Income Tax | 43,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.05% in the last 52 weeks. The beta is 1.38, so ELEV's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -95.05% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 23.27 |
| Average Volume (20 Days) | 2,050,696 |
Short Selling Information
The latest short interest is 8.75 million, so 14.78% of the outstanding shares have been sold short.
| Short Interest | 8.75M |
| Short Previous Month | 8.56M |
| Short % of Shares Out | 14.78% |
| Short % of Float | 23.65% |
| Short Ratio (days to cover) | 9.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -44.70M |
| Pretax Income | -39.66M |
| Net Income | -44.49M |
| EBITDA | -44.68M |
| EBIT | -44.70M |
| Earnings Per Share (EPS) | -$0.78 |
Full Income StatementBalance Sheet
The company has $93.18 million in cash and $31.13 million in debt, giving a net cash position of $62.05 million or $1.05 per share.
| Cash & Cash Equivalents | 93.18M |
| Total Debt | 31.13M |
| Net Cash | 62.05M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 60.03M |
| Book Value Per Share | 1.02 |
| Working Capital | 90.26M |
Full Balance SheetCash Flow
| Operating Cash Flow | -36.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | -36.36M |
| FCF Per Share | -$0.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |